Friday, November 20, 2026
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
   

You can get e-magazine links on WhatsApp. Click here

POLICY & REGULATIONS

India to launch indigenous bird flu vaccine for poultry
Friday, 20 November, 2026, 11 : 00 AM [IST]
Our Bureau, Mumbai
India will launch its first indigenously developed Inactivated H5N1 (Clade 2.3.2.1a) vaccine for chickens on November 20, 2026. Union Minister of Agriculture and Farmers Welfare and Rural Development Shivraj Singh Chouhan will dedicate the vaccine to the nation at the ICAR-National Institute of High Security Animal Diseases (ICAR-NIHSAD), Bhopal. The vaccine has been developed by ICAR-NIHSAD and is the first indigenous vaccine in India targeting the H5N1 Highly Pathogenic Avian Influenza (HPAI) virus of Clade 2.3.2.1a.

Highly Pathogenic Avian Influenza, commonly known as bird flu, is a serious poultry disease that can cause nearly 100 per cent mortality among infected birds. Outbreaks result in substantial financial losses for poultry farmers due to large-scale culling and trade restrictions. The disease also affects the poultry supply chain, prices of poultry products and farmers' livelihoods. Since its first detection in India in 2006, the country has reported more than 500 combined outbreaks involving H5N1 and H5N8 subtypes.

The economic consequences of a major bird flu outbreak could be significant, with India's GDP growth potentially declining by up to 1.5 per cent. More than 20 per cent of the country's poultry population could also be at risk if the disease spreads unchecked. The 2006 outbreak resulted in estimated direct and indirect losses of Rs 2,200–3,000 crore, while an outbreak in Manipur caused losses equivalent to 0.5 per cent of the state's GDP.

Beyond its economic impact, H5N1 is also a public health concern. According to the World Health Organization (WHO), 1,003 human cases of H5N1 avian influenza, including 479 deaths, have been reported across 25 countries, including India, since 2003.

Studies have identified the H5N1 strain Clade 2.3.2.1a as responsible for most bird flu outbreaks in chickens. In recent years, infections involving this strain have also been detected in several animal species, including mammals, along with three human cases. Controlling its spread is therefore important to minimise losses in the poultry sector and reduce the risk of transmission to other animals and humans.

Currently, no specific commercial vaccine is available against the H5N1 virus of Clade 2.3.2.1a. The indigenous vaccine developed by ICAR-NIHSAD is expected to address this gap by providing protection against the Clade 2.3.2.1a H5N1 strains circulating in India. Its development marks an important step towards strengthening disease preparedness, protecting poultry farmers and supporting the country's poultry industry.
 
Print Article Back
Post Your commentsPost Your Comment
* Name :
* Email :
  Website :
Comments :
   
   
Captcha :
 

 
 
 
 
Food and Beverage News ePaper
 
 
Interview
“MoFPI supporting processing entities with incremental sales incentives”
Past News...
 
FORTHCOMING EVENTS
 

FNB NEWS SPECIALS
 
Advertise Here
 
Subscribe Here
 
Case Study
From functional to premium: How Well Bell Foods redesigned for Nepal's modern-trade shelf
Past News...



Home | About Us | Contact Us | Feedback | Disclaimer
Copyright © Food And Beverage News. All rights reserved.
Designed & Maintained by Saffron Media Pvt Ltd